20 Stocks Moving in Tuesday's Pre-Market Session
$AIM
$ALJJ
$AQB
$ASTS
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Business Services
Consumer Discretionary
Gainers
- Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for Nanocyn hospital-grade disinfectant in the U.S.
- Field Trip Health Ltd. (NASDAQ:FTRP) rose 28.7% to $1.39 in pre-market trading. The company, on April 28, said that it will be issuing shares in Field Trip Discovery Unit to be renamed Reunion Neuroscience.
- SoundHound AI, Inc. (NASDAQ:SOUN) rose 22.5% to $13.41 in pre-market trading after jumping over 68% on Monday.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 11.4% to $1.17 in pre-market trading.
- Harbor Custom Development, Inc. (NASDAQ:HCDI) rose 10% to $3.52 in pre-market trading after climbing 13% on Monday.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) rose 9.5% to $1.15 in pre-market trading after jumping 15% on Monday.
- AST SpaceMobile, Inc. (NASDAQ:ASTS) rose 9.1% to $8.68 in pre-market trading. AST SpaceMobile won an experimental license from the Federal Communications Commission (FCC) supporting its U.S.-based testing of the BlueWalker 3 satellite.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) shares rose 9% to $0.1788 in pre-market trading after declining around 7% on Monday.
- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) rose 8.5% to $0.5995 in pre-market trading. Qualigen Therapeutics recently named Shishir Sinha to lead the Company’s diagnostics division.
- AquaBounty Technologies, Inc. (NASDAQ:AQB) rose 7.4% to $1.46 in pre-market trading.
- ALJ Regional Holdings, Inc. (NASDAQ:ALJJ) rose 7.1% to $2.55 in pre-market trading.
Don’t forget to check out our premarket coverage here .
Losers
- Chegg, Inc. (NYSE:CHGG) shares fell 37.4% to $15.65 in pre-market trading after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates. Piper Sandler downgraded Chegg from Overweight to Neutral and lowered the price target from $44 to $21.
- Borqs Technologies, Inc. (NASDAQ:BRQS) shares fell 16.3% to $0.2230 in pre-market trading after dipping around 22% on Monday.
- Hayward Holdings, Inc. (NYSE:HAYW) fell 14.9% to $14.37 in pre-market trading after the company reported a secondary offering of 22.5m shares of common stock by selling stockholders.
- Better Therapeutics, Inc. (NASDAQ:BTTX) fell 13.4% to $1.74 in pre-market trading after jumping over 120% on Monday.
- Luokung Technology Corp. (NASDAQ:LKCO) shares fell 9.4% to $0.5211 in pre-market trading after jumping 17% on Monday.
- Surgalign Holdings, Inc. (NASDAQ:SRGA) fell 8.3% to $0.1870 in pre-market trading. Surgalign Spine Technologies is expected to release financial results from the first quarter 2022 on May 10th, 2022.
- Redbox Entertainment Inc. (NASDAQ:RDBX) fell 8.1% to $7.84 in pre-market trading after climbing around 43% on Monday.
- Cemtrex, Inc. (NASDAQ:CETX) fell 8% to $0.38 in pre-market trading after gaining over 8% on Monday.
- DuPont de Nemours, Inc. (NYSE:DD) fell 3.5% to $63.50 in pre-market trading after the company posted reported downbeat results for its first quarter and issued weak guidance for FY22.